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DIETARY SUPPLEMENTATION WITH MAGNESIUM CITRATE MAY IMPROVE 
PANCREATIC METABOLIC INDICES IN AN ALLOXAN-INDUCED DIABETES 
RAT MODEL 
 




The purpose of the current study was to evaluate the protective properties of dietary magnesium supplementation on 
pancreatic tissue of rats with alloxan-induced diabetes mellitus. Twenty-five male Wistar rats were split into five groups 
(control, diabetes, diabetes with 100 mg Mg daily, diabetes with 250 mg Mg daily, diabetes with 500 mg Mg daily) with 
feeding supplementation starting on day 1, diabetes induction on day 21, and animal sacrifice on day 30. Fasting glucose in 
blood serum was measured on days 21, 25, 27, and day 30. Glucose metabolism enzymes, namely, lactate dehydrogenase 
and glucose-6-phosphate dehydrogenase, were measured in pancreatic tissue upon the sacrifice, as well as lipid 
peroxidation, antioxidant system protective enzymes (catalase and superoxide dismutase), and glutathione system 
components (glutathione reductase, glutathione peroxidase, and glutathione reduced). Pearson correlation coefficients 
showed strong negative correlation between serum glucose (control and diabetic animals) and glucose metabolism 
enzymes, catalase, superoxide dismutase, glutathione peroxidase in pancreatic tissue (r >-0.9, p <0.05), moderate negative 
correlation with reduced glutathione (r = -0.79, p <0.05), moderate positive correlation with lipid peroxidation index  
(r = +0.67, p <0.05), weak correlation with glutathione reductase (r = -0.57, p <0.05). Magnesium supplementation slowed 
down diabetes onset considering fasting glucose levels in rats (p <0.05), as well as partially restored investigated 
dehydrogenase levels in the pancreas of rats comparing to diabetes group (p <0.05). The lipid peroxidation index varied 
between treatments showing the dose-dependent influence of Mg
2+
. Magnesium supplementation partially restored catalase 
and superoxide dismutase activities in pancreatic tissue, as well as glutathione peroxidase and reduced glutathione levels  
(p <0.05), while glutathione reductase levels remained unaffected (p >0.05). The obtained results suggested a model, where 
magnesium ions may have a possible protective effect on pancreatic tissue against the negative influence of alloxan inside 
β cells of the pancreas. 
Keywords: alloxan; diabetes; rat model; magnesium oral supplementation; pancreas 
INTRODUCTION 
 Diabetes mellitus is a major health-related problem 
worldwide, with the number of people with diabetes 
increasing from 108 million in 1980 to 422 million in 
2014, according to the WHO (WHO, 2018). Dietary 
habits, together with a genetic predisposition, may 
influence diabetes mellitus development in healthy 
individuals. Magnesium is a macroelement involved in 
virtually all biochemical pathways in cells (de Baaij, 
Hoenderop and Bindels, 2015). Considering its 
importance, the serum Mg
2+
 levels are maintained between 
0.7 and 1.05 mM level in blood serum (de Baaij, 
Hoenderop and Bindels, 2015). Low serum Mg
2+
 levels 
could be attributed to either dietary restriction, impaired 
intestinal absorption, or increased renal wasting. 
Hypomagnesemia has been long reported as a risk factor 
for type 2 diabetes mellitus development, as a contributing 
reason for (Dong et al., 2011), as well as a consequence of 
insulin resistance (Pham et al., 2007; Chaudhary, 
Sharma and Bansal, 2010). “A vicious cycle” of 
hypomagnesemia described by Gommers et al. (2016) 
implies the necessity of Mg
2+
 for insulin receptor 
autophosphorylation and therefore preventing insulin 
resistance from one side, while circulating excess of 
insulin being able to activate renal Mg
2+
 channel transient 
receptor potential melastatin type 6, which stimulates the 
secretion of Mg
2+
 with urine. Magnesium influences 
glucose metabolism and insulin action in several ways. 
Firstly, it is involved in the autophosphorylation of  
β-subunits of insulin receptor through tyrosine kinase 
activity binding to ATP. Rats with hypomagnesemia had 
reduced levels of the phosphorylated insulin receptor, 
mimicking insulin resistance (Paxton and Ye, 2005; 
Suárez et al., 1995). Secondly, recent studies showed that 
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oral Mg
2+
 supplementation increased GLUT1 and GLUT4 
expression in muscles of STZ-induced diabetic rats and 
mice, resulting in lowering serum glucose levels and its 
uptake by muscle tissue (Biddinger and Kahn, 2006; 
Solaimani et al., 2014). Thirdly, Mg
2+
 is an important 
anti-inflammatory mediator, and hypomagnesemia 
increased production of proinflammatory interleukin 1, 
tumor necrosis factor-α by adipocytes, causing the 
production of reactive oxygen species that may lead to 
chronic inflammation, insulin resistance, and reduced 
GLUT4 activity (Rodriguez-Moran and Guerrero-
Romero, 2004; Weglicki et al., 1992). And finally, Mg
2+
 
affects insulin production in pancreatic β cells. Under 
normal physiological conditions, increased blood glucose 
levels stimulate the influx of glucose into β-cell via 
GLUT2 transporter, followed by its conversion to glucose-
6-phosphate (G6P) by glucokinase, which is a “ glucose 
sensor” for insulin secretion. G6P is further metabolized 
through glycolysis and Krebs cycle, producing ATP, 
excess of which directly induces closure of KATP channel 
Kir6.2. Closure of this channel causes depolarization of 
plasma membrane, the opening of a voltage-dependent 
influx of Ca
2+
 ions, which causes exocytosis of insulin into 
the bloodstream. From one side, Mg
2+
 directly positively 
influences glucokinase activity by acting as a cofactor of 
adenine nucleotides, though it may be happening even at 
sub-physiological levels. Conversely, Mg
2+
 initiates KATP 
channel opening through MgATP, negatively affecting  
L-type Ca
2+
 channels, an influx of Ca
2+
 into β cells, and 
restraining insulin release. However, those are short-time 
negative consequences, while in a long run Mg
2+
 may 
improve β cells functionality, similar to cardiomyocytes, 
where low Mg
2+
 level was shown to decrease expression of 
L-type Ca
2+
 channels (Gommers et al., 2016). It was 
shown that in humans without diabetes decreased serum 
Mg
2+
 was associated with decreased insulin secretion 
(Rodríguez-Morán and Guerrero-Romero, 2011). 
Similarly, supplementation of individuals without diabetes 
with MgCl2 significantly improved β-cell function and 
insulin secretion (Guerrero-Romero and Rodríguez-
Morán, 2011). 
 Alloxan is a cytotoxic glucose analog, which selectively 
binds to GLUT2 receptors of pancreatic β cells and enters 
them, causing necrotic cell death, thus modeling type 1 
diabetes (Lenzen, 2008). Alloxan is highly unstable in 
solutions with neutral pH and bloodstream and 
decomposes to alloxanic acid within minutes (Szkudelski, 
2001). A single intraperitoneal injection of 150 mg.kg
-1
 of 
live weight is sufficient to cause alloxan-induced diabetes 
in fasting rats, causing permanent hyperglycemia between 
24 to 48 hours post-injection (Ighodaro, Adeosun and 
Akinloye, 2017). Being a thiol reagent, alloxan inhibits 
glucokinase (“glucose sensor”), and, therefore, glucose 
phosphorylation in β cells, initially causing rapid ATP 
increase followed by rapid insulin secretion and severe 
hypoglycemia, followed by halting and inhibition of 
insulin secretion (Szkudelski, 2001; Lenzen, 2008; 
Ighodaro, Adeosun and Akinloye, 2017). More 
importantly, alloxan enters redox cyclic reaction coupled 
with its oxidized form, dialuronic acid, which 
spontaneously autooxidizes to generate toxic superoxide 
radicals and hydrogen peroxide, commonly known as 
reactive oxygen species (ROS) (Munday, 1988; 
Winterbourn and Munday, 1989; Lenzen, 2008). Thiol 
groups, specifically, but not limited, to reduced glutathione 
are required for dialuronic acid production (Szkudelski, 
2001). A temporary compound of alloxan-glutathione, 
namely, “compound 305”, is formed during each cycle, 
resulting in decreased GSH/GSSG ratio and depletion of 
reduced glutathione (Munday, 1988; Szkudelski, 2001). 
The ultimate damage is caused by another ROS, hydroxyl 
radicals, which acts together with superoxide radicals and 
hydrogen peroxide, causing massive cellular damage, and 
ultimately apoptosis. Interestingly, few reviews noted 
massive Ca
2+
 influx in β cells and subsequent disruption of 
intracellular calcium homeostasis as one of the major 
reasons for β cell necrosis as well (Szkudelski, 2001; 
Ankur and Shahjad, 2012). Antioxidant enzymes, 
namely, superoxide dismutase (transforming superoxide 
radical into hydrogen peroxide), and catalase 
(transforming hydrogen peroxide into water and oxygen), 
protect cells against ROS produced by alloxan (Grankvist 
et al., 1979; Winterbourn and Munday, 1989). 
Glutathione peroxidase also detoxifies cells from hydrogen 
peroxide, though it requires reduced glutathione as  
a substrate. Cell debris, produced by necrotic dying β cells, 
are quickly scavenged by macrophages. 
 The purpose of the current study was to evaluate the 
influence of magnesium dietary supplementation on the 
duration and late progression of alloxan-induced diabetes 
related to pancreatic metabolic indices, including enzymes 
of glucose metabolism (lactate dehydrogenase, LDH, and 
glucose-6-phosphate dehydrogenase, G6PD), state of lipid 
oxidation (lipid hydroperoxide, LOOH), antioxidant 
enzymes (catalase, CAT, and superoxide dismutase, SOD), 
and glutathione system (glutathione peroxidase, G-Per, 
glutathione reductase, G-Red, and reduced glutathione, 
GSH). To the best of our knowledge, this study relative to 
pancreatic health state after late progression of alloxan-
induced diabetes, with or without oral magnesium 
supplementation, was not performed yet. Additionally, we 
measured fasting serum glucose levels in rats with alloxan-
induced diabetes, with or without dietary magnesium 
supplementation, as a time-dependent variable influenced 
by diabetes onset and progression. 
 
Scientific hypothesis 
 We hypothesize that magnesium supplementation will 
not prevent, but may reduce the toxic effects of alloxan on 
pancreatic β cells. This may include the restoration of 
pancreatic glucose metabolism enzyme function back to 
the levels of the healthy control rats; decrease in LOOH 
comparing to alloxan-treated rats, reducing their levels 
back to the levels found in healthy control rats; activation 
of CAT and SOD, as protectors against ROS; increase in 
levels of G-SH and glutathione system enzymes, namely, 
G-Red and G-Per. Additionally, we hypothesize that 
magnesium supplementation may reduce fasting blood 
glucose levels in alloxan-induced diabetic rats due to the 
improved pancreatic function. 
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MATERIALS AND METHODOLOGY 
The alloxan-induced diabetes rat model 
 Twenty-five white Wistar rats (ca. 140 g each, same age) 
were used for the experiments. The animals were kept in 
cages under standard conditions (20 – 25 °C, 40 – 45% air 
relative humidity) with free access to compound feed, 
while water was strictly supplemented (20 mL daily). 
Compound feed composition remained unknown. All 
procedures with animals were carried out according to the 
“European Convention for the Protection of Vertebrate 
Animals for Experimental and Other Scientific Purposes” 
(Strasbourg, France, Council of Europe, March 18, 1986) 
and were approved by the local institutional ethical 
committee. 
 The rats were divided into five groups, 5 rats per group: 
intact control (group 1, C); induced diabetes (group 2, D); 





daily dose) with diabetes (group 3, Mg100-D); magnesium 
(250 mg.kg
-1
) with diabetes (group 4, Mg250-D); 
magnesium (500 mg.kg
-1
) with diabetes (group 5, Mg500-
D). Day 0 was the date of dietary supplementation start, 
while alloxan induction of diabetes was performed on day 
21, and all animals were sacrificed on day 30. Magnesium 
citrate (C6H6O7Mg) was dissolved in tap water in the 
amount of 6.17, 15.44, and 30.88 mg per mL 
corresponding to 14, 35, or 70 mg Mg
2+
 in 20 mL water 
per animal, which relates to 100, 250, and 500 mg Mg
2+
 
per kg of live weight. A single intraperitoneal injection of 
alloxan monohydrate ("Sinbias", Ukraine) in 0.85% 
physiological saline was performed on each rat from 
groups 2, 3, 4, and 5 (150 mg.kg
-1
 of body weight) after 
24-hours fasting on the 21
st
 day from the start of the 
experiment. All animals were sacrificed under ether 
anesthesia by decapitation on day 30, followed by removal 
of the pancreas within 2 minutes after the death. The 
removed pancreas was kept on ice for 5 to 6 minutes 
followed by bleeding through repeated perfusion with 
physiological saline (0.85% NaCl, 4 °C). The pancreas 
was chopped coarsely by scissors. One gram of chopped 
tissue was homogenized with 9.0 mL of 5 mM Tris-HCl 
buffer (1:10 dilution), pH 7.4, for 50 seconds at 0 °C 
(MRTU-421505-63, Ukraine). The homogenate was 
filtered through two layers of cheesecloth into a centrifuge 
tube followed by centrifugation (3,000 g, 10 minutes,  
0 °C). The supernatant was used immediately for 
biochemical markers quantification and called “tissue 
sample” throughout the research paper. 
 All reagents used for the experiments, if not specified, 
were of laboratory grade or better. 
 
Fasting blood serum glucose determination 
 Glucose determination was done on venous blood drawn 
from rat tails using glucose oxidase method (Gamma TM 
mini glucometer) after at least 6-hours fasting on days 21, 
23, 25, 27, and day 30 (sacrifice day). The principle of the 
method is based on the reaction catalyzed by glucose 
oxidase: 
  Glucose + O2 → Glucolactone + H2O2                (1) 
 
using test strips and calibration strips supplied by the 
manufacturer. 
 
Lipid hydroperoxide (LOOH) determination 
 LOOH determination is based on the interaction of 
ethanol extracts of lipid hydroperoxides with ammonium 
thiocyanate after precipitation of proteins with 
trichloroacetic acid (TCA). The original method developed 
by Wagner, Clever and Peters (1947), and later updated 
and modified by Mihaljević, Katušin-Ražem and Ražem 
(1996), was adapted. Briefly, 0.2 mL of tissue sample was 
placed in a centrifuge tube with 2.8 mL of ethanol (95%) 
and 0.05 mL of 50% TCA at 4 °C. The tube was tightly 
closed and shaken for 5 minutes, followed by 
centrifugation, resulting in protein precipitation (3,000 g, 
10 minutes, 4 °C). 1.5 mL of the resulting supernatant was 
mixed with 1.2 mL of ethanol, 0.02 mL of concentrated 
HCl, and 0.03 mL of 1% Mohr’s salt, Fe(NH4)2(SO4)2, in 
3% HCl. The mixture was shaken, followed by addition of 
0.2 mL of 20% NH4SCN. Optical absorbance (A480) was 
measured after 10 minutes of incubation time 
(spectrophotometer UNICO S1205, λ = 480 nm). The 
control sample was prepared by tissue sample replacement 
with 0.2 mL of deionized water. LOOH in samples was 
calculated using the following equation: 
 
  ΔA480 LOOH.g
-1
 = DF x (A480 exp - A480control)    (2) 
 
 The obtained results were expressed as the difference in 
optical absorbance between experimental and control 
samples (λ = 480 nm), adjusted to 1 g of pancreatic tissue 
(ΔA480 LOOH.g
-1
) by dilution factor DF. 
 All reagents used for the experiments, if not specified, 
were of laboratory grade or better. 
 
Total protein determination 
 Protein concentration in the tissue sample was 
determined by the Lowry method using standardized kits 
(SIMCO Ltd, Ukraine) according to the manufacturer’s 
instructions. The method is based on the formation of non-
ferrous products of the interaction of aromatic amino acids 
with the Folin-Ciocalteu reagent in combination with the 
biuret reaction to peptide bonds of the protein (Lowry et 
al., 1951). The results were expressed in mg of protein per 
mL of the tissue sample using spectrophotometer UNICO 
S1205 for absorbance measurements. The protein 
concentration of tissue samples from the pancreas of each 
rat was used to estimate enzyme activity per mg of protein 
in the subsequent analysis of SOD, CAT, G-Per, G-Red, 
G6PD, and LDH enzymatic activities in tissue samples. 
 
Superoxide dismutase (SOD) determination  
 The principle of the method for superoxide dismutase 
(EC 1.15.1.1) activity determination is based on the ability 
of the enzyme to compete with nitroblue tetrazolium for 
the superoxide anion radicals, which are formed as a result 
of aerobic interaction of NADH and phenazine 
methosulfate (Ponti et al., 1978). As a result of this 
reaction, nitroblue tetrazolium is reduced to formazan dye. 
In the presence of SOD, the percentage of nitroblue 
tetrazolium reduction is reduced. Enzyme activity was 
determined by the percentage of blockage of formazan dye 
formation (Durak et al., 1993). Briefly, 1.5 mL of 
incubation mixture (containing 37 mg  EDTA-Na2, 330 mg 
nitrotetrazolium blue, 55 mg phenazine methosulfate, and 
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0.3 mL 0.15 M phosphate buffer, pH 7.8) was mixed with 
0.1 mL of a tissue sample and 0.1 mL of 1 mM NADH in 
Tris-EDTA buffer (pH 8.0) followed by 10 minutes 
incubation at room temperature. Optical absorbance was 
measured against water (UNICO S1205,  λ = 540 nm). The 
control sample was prepared using distilled instead of  
a tissue sample. The enzyme activity was determined with 
the following equation: 
 
      % blockage = 100 x (Ac – At)/Ac                 (3) 
 
where Ac – optical absorbance of the control sample; At  – 
optical absorbance of the test sample. Superoxide 
dismutase activity was expressed in relative units per 1 mg 
of protein (1 relative unit = 50% blocking). 
 
Catalase (CAT) determination 
 The principle of the method for catalase (EC 1.11.1.6) 
activity determination is based on the ability of H2O2 to 
form a stable colored complex with molybdenum salts. 
According to Góth (1991), the color intensity of 
molybdenum peroxide compounds depends on the amount 
of H2O2 in solution; and therefore, on the activity of 
catalase in the sample. The catalase reaction was started by 
mixing 0.1 mL of a tissue sample with 1 mL of 0.05 M 
Tris-HCl buffer (pH 7.8) and 2 mL of 0.03% H2O2. Blank 
included 1 mL of 4% (NH4)2MoO4 in 0.025 N H2SO4 and 
2.0 mL H2O2. The reaction in the test sample was stopped 
after 10 minutes by adding 1 mL of 0.25 N H2SO4 and  
1 mL of 4% (NH4)2MoO4. To complete the blank, 1 mL of 
0.25 N H2SO4 and 0.1 mL of tissue sample was added to 
the blank. 
 Samples were centrifuged for 5 minutes at 3,000 g. 
Optical absorbance was determined spectrophotometrically 





 was calculated using the following 
equation: 
 
             Ea= (ΔA x DF)/(Ԑ x t x C x l)                              (4) 
 
 Where: ΔA – difference between the optical absorbance 
of blank and test samples; DF – dilution factor of the 
original tissue sample; Ԑ – molar extinction coefficient of 
the H2O2 complex with ammonium molybdate at λ = 410 




; C – tissue sample protein 
concentration, mg.mL
-1
; t – reaction time, 10 minutes,  
l – optical path, 1 cm. 
 All reagents used for the experiments, if not specified, 
were of laboratory grade or better. 
 
Glutathione peroxidase (G-Per) determination 
 The activity of glutathione peroxidase (EC 1.11.1.9) was 
measured through the oxidation rate of reduced glutathione 
in the presence of tertiary butyl hydroperoxide (Moin, 
1996). Change in absorbance is due to the interaction 
between SH-groups and Ellman's reagent (0.01 M solution 
of 5,5'-dithiobis-2-nitrobenzoic acid (DTNB) in methanol) 
with the formation of a colored product,  
5'-thio-2-nitrobenzoic acid. The amount of the latter is 
directly proportional to the number of -SH groups that 
reacted with Ellman’s reagent. Briefly, 0.83 mL of 4.8 mM 
reduced glutathione in 0.1 M Tris-HCl buffer (pH 8.5), 
containing 6 mM EDTA and 12 mM NaN3, was added to 
0.2 mL of the tissue sample. The mixture was incubated at 
37 °C for 10 minutes. Following incubation, 0.07 mL of  
20 mM tertiary butyl hydroperoxide was added and the 
mixture was incubated for an additional 5 minutes. The 
reaction was stopped by adding 0.2 mL of 20% 
trichloroacetic acid at 4 °C. A blank sample was prepared 
identically, but with distilled water instead of the tissue 
sample. The samples were centrifuged for 10 minutes at 
3000 g. The supernatant (0.02 mL) was mixed with 2 mL 
of 0.1 M Tris-HCl buffer (pH 8.5) and 0.02 mL of Elman's 
reagent. After 5 minutes incubation, the samples were 
analyzed spectrophotometrically (UNICO S1205,  





 protein and calculated using the following 
equation: 
 
             Ea = (ΔA x DF x Cs)/(As x t x C)                        (5) 
 
 Where: ΔA – the difference between optical absorbance 
of the control and experimental samples; DF – dilution 
factor of the original tissue sample; As – absorbance of the 
standard G-SH solution; Cs – concentration of the standard 
G-SH solution; C – protein concentration in the tissue 
sample, mg.mL
-1
; t – reaction time, 5 minutes. 
 
Glutathione reductase (G-Red) determination 
 The activity of glutathione reductase (EC 1.8.1.7) was 
determined spectrophotometrically as the rate of 
glutathione reduction in the presence of NADPH as 
suggested by Carlberg and Mannervik (1985). The 
reaction mixture contained 2 mL of 0.15 M phosphate 
buffer, pH 7.4; 0.2 mL of 10 mM EDTA; 0.5 mL of  
7.5 mM oxidized glutathione, 0.1 mL of 2 mM NADPH; 
and 0.2 mL of the test sample. The enzyme activity was 
determined by measuring the reduction in NADPH content 
within 10 minutes at 37 °C (UNICO S1205, λ =340 nm). 





 protein and calculated using 
equation 4, where ΔA – absorbance difference between the 
start and end time of the reaction; DF – dilution factor of 
the tissue sample; Ԑ – molar extinction coefficient for 




; t – reaction time, 10 minutes. 
 
Reduced glutathione (G-SH) determination 
 The content of reduced glutathione (G-SH) was 
determined by the level of 5'-thio-2-nitrobenzoic acid 
formation as a result of the interaction of the glutathione – 
SH groups with 5,5'-dithiobis-2-nitrobenzoic acid (DTNB) 
at λ = 412 nm as per method developed by Beutler, Duron 
and Kelly (1963). The following reagents were used:  
a precipitating reagent (glacial metaphosphoric acid –  
6.68 g; EDTA – 0.80 g; sodium chloride – 120.0 g; 
distilled water to 400 mL); 0.3 M Na2HPO4 solution in 
distilled water; Elman's reagent (0.04% solution of  
5.5-dithiobis-2-nitrobenzoic acid in 1% solution of 
trisodium citrate) (Rahman, Kode and Biswas, 2006). 
 Stage I. Sample: tissue sample – 2 mL, precipitating 
reagent – 3 mL; control: distilled water – 2 mL, 
precipitating reagent – 3 mL. The mixtures were kept at 
room temperature for 5 minutes followed by centrifugation 
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at 3,500g, through which protein-free supernatant was 
obtained. 
 Stage II. Sample: supernatant from stage I – 2 mL, 0.3 M 
Na2HPO4 – 8 mL, Elman's reagent – 0.1 mL; Control: 
control supernatant from stage I – 2 mL; 0.3 M Na2HPO4 – 
8 mL, Elman reagent– 0.1 mL. After 5 minutes of 
incubation, the absorbance measurement of the sample 
against control was performed (UNICO S1205,  
λ = 412 nm). The calculation of the amount of G-SH in the 
pancreas in mmoles per gram of tissue was estimated 
against G-SH standard solution with known concentration 
Cs using equation 6: 
 
                   NGSH = (ΔA412 x DF x Cs)/A412s                     (6) 
 
 All reagents used for the experiments, if not specified, 
were of laboratory grade or better. 
 
Lactate dehydrogenase (LDH) and glucose-6P-
dehydrogenase (G6PD) determination 
 LDH and G6PD enzymatic activity were determined 
using spectrophotometric methods based on the coupled 
oxidation/reduction systems of nicotinamide coenzymes 
(UNICO S1205, 37 °C, NADH and NADPH molar 
extinction coefficient ε = 6220 at λ = 340 nm,  
t = 5 minutes of enzymatic reaction). The reaction was 
carried in 0.2 М tris-НСl buffer (рН 7.5) with a total 
volume of 3 mL, including 0.2 mL of the tissue sample. 









 М MgCl2 (Sevela and Tovarek, 1959). 
G6PD – 1×10
-3
 М glucose-6-phosphate, 5×10
-3





 (Evans, 2009). 





protein and calculated using equation 4. 
 All reagents used for the experiments, if not specified, 
were of laboratory grade or better. 
 
Statistical analysis 
 Two-factorial ANOVA was used to analyze the influence 
of treatment (D, Mg100-D, Mg250-D, Mg500-D) and time 
of experiment onset (day 21, day 25, day 27, and day 30), 
as well as their interaction (treatment x time), on the 
fasting glucose levels in rats. If the influence of factors or 
their interaction was significant (p <0.05), means were 
separated using the Fisher LSD procedure. 
 Pearson correlation coefficients were calculated between 
paired serum glucose levels of the control (C) and 
diabetes-induced rats (D) on day 30 and LOOH, SOD, 
CAT, G-Per, G-Red, G-SH, G6PD, and LDH levels in 
pancreas after animal sacrifice. 
 One-way ANOVA was used to analyze the influence of 
treatment (C, D, Mg100-D, Mg250-D, Mg500-D) on carbs 
metabolism enzyme activity, namely, G6PD and LDH; on 
lipid oxidative damage index, namely, LOOH level; on 
antioxidant enzymes activity, namely, SOD and CAT; and 
on glutathione system, namely, G-Per and G-Red activities 
and G-SH levels, in pancreatic tissue. If the influence of 
the factor was significant (p <0.05), means were separated 
using the Fisher LSD procedure. 
 
RESULTS AND DISCUSSION 
 As expected, oral magnesium supplementation did not 
prevent alloxan induction of diabetes, though somewhat 
significantly slowed its progression (Figure 1, p <0.05). 
There was a significant influence of both factors, treatment 
(D, Mg100-D, Mg250-D, Mg500-D) and time of 
experiment onset (day 21, day 25, day 27, and day 30), on 
fasting serum glucose concentration (p <0.05, Figure 1), 
though their interaction (treatment x time) did not affect  
(p >0.05). Glucose levels increased gradually with the time 
of the experiment onset (Figure 3), while 250 mg.kg
-1
 
magnesium-dose had the most profound effect on the 
fasting glucose reduction (Figure 2). Similarly, Abayomi 
et al. (2011) showed that a single intraperitoneal injection 
of magnesium (100 and 150 mg.kg
-1
 live weight) one hour 
before alloxan-induced diabetes (120 mg.kg
-1
 live weight) 
in rats improved fasting glucose levels on days 2, 5, 7, and 
10 compared to diabetes alone, but still was significantly 
higher comparing to control. Additionally, Ige et al. 
(2010) showed a similar effect of a single intraperitoneal 
injection of magnesium (100 mg.kg
-1
) one hour before 
diabetes induction in rats even at a higher level of alloxan 
dose (150 mg.kg
-1
 live weight). 
 The Pearson correlation coefficients between serum 
glucose levels (C and D groups) and investigated indices 
are shown in Table 1. The increased glucose levels, as  
a result of alloxan-induced diabetes, had strong negative 
correlations with LDH and G6PD enzymes, possibly 
indicating cellular damage and reduced metabolic activity 
of pancreatic cells; strong negative correlations with CAT, 
SOD, G-Per, possible indicating damage of antioxidative 
enzyme system as a result of confronting ROS produced 
by alloxan; medium negative correlations with G-SH, 
indicating G-SH consumption and possible impairment 
during alloxan redox cycling with dialuronic acid. A weak 
negative correlation was observed with G-Red, and 
moderate positive correlation with LOOH, indicating 
residual oxidative damage to the lipids of the cell 
membranes. These weak positive correlations could be 
because alloxan-induced diabetes was already established 
and necrotic β cells already removed by macrophages 
before the day of animal sacrifice (day 30). 
 Polyunsaturated fatty acids (PUFAs), which in their 
esterified state are present in membrane or storage lipids, 
are prone to ROS-induced peroxidation, resulting in the 
damage to the biomembranes. Final products of lipid 
peroxidation (LOOH) are reactive aldehydes, which are 
relatively stable, can diffuse far from the location of 
oxidative injury, and may act as second messengers or free 
radicals (Gasparovic et al., 2013). Levels of LOOH were 
significantly different between treatments as shown in 
Table 2 (p <0.05). LOOH increased non-significantly in 
the diabetes group, and was significantly decreased 
compared to diabetes in Mg250-D group (p <0.05). 
Paradoxically, the highest LOOH levels were observed at 
high Mg
2+
 supplementation (500 mg.kg
-1
), possibly 
showing that at such levels influence of Mg
2+
 may be 
negative, which is also confirmed by increased fasting 
serum glucose in this group (Figure 2). Though the major 
effect of targeted alloxan cytotoxic action on β cells is 
massive production of ROS, such as superoxide radical, 
hydrogen peroxide, and hydroxyl radical (Munday, 1988; 
Winterbourn and Munday, 1989), the result is apoptosis 
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of β cells followed by cell debris removal. The 
determination of LOOH was done long after alloxan major 
damage and after its degradation in rat body (day 10 after 
the onset of diabetes), and presumably all damaged cells 
were either removed or repaired back to normal. 
Therefore, LOOH values could be non-informative. 
 Another possibility is the lack of the precision in 
determination of these values due to the low number of 
observations, causing an absence of significant differences 
between treatments. 
 Evaluation of enzyme activity, due to their protein nature, 
and sensitivity to various processing conditions, as well as 
pathological processes, is widely used in industry, life 
science, and medical research (Tokarskyy et al., 2009; 
Yaremchuk and Posokhova, 2011; Lykhatskyi et al., 
2019). 
 Table 1 Pearson correlation coefficients (p <0.05) between fasting serum glucose levels in control (C) and diabetic (D) 
groups vs. investigated indices (LOOH, SOD, CAT, G-Per, G-Red, G-SH, LDH, G6PD). 
 LOOH SOD CAT G-per G-red G-SH LDH G6PD 
Pearson correlation 
coefficient, r 
+0.67 -0.92 -0.98 -0.91 -0.57 -0.79 -0.93 -0.95 
 
 
 Table 2 Influence of treatment (control, diabetes, diabetes with 100, 250, and 500 mg Mg supplementation) on LOOH 
levels in pancreatic tissue of rats upon sacrifice on day 30, with standard deviation included.  
 C ±SD D ±SD Mg100-D ±SD Mg250-D ±SD Mg500-D ±SD 
LOOH, ΔA480.g
-1 0.133 ±0.014 bd* 0.165 ±0.021 b 0.143 ±0.014 bc 0.133 ±0.013 cd 0.210 ±0.011  a 





 Figure 1 Mean values of fasting blood serum glucose levels in control (C), diabetic (D), magnesium supplemented 
diabetic rats (Mg100-D, Mg250-D, Mg500-D) as measured on days 21, 25, 27, and sacrifice day (day 30). Control (C) is 
shown for reference. Error bars reflect standard deviations. Note: Means with the same letters are not significantly 
different (p >0.05). 
 
 
Table 3. Influences of treatment (control, diabetes, diabetes with 100, 250, and 500 mg Mg supplementation) on G-Per 
(p <0.05), G-Red (p =0.7), and G-SH (p <0.05) levels in pancreatic tissue of rats upon sacrifice on day 30, with standard 
deviation included. 
 C ±SD D ±SD Mg100-D ±SD Mg250-D ±SD Mg500-D ±SD 
G-Per, μmol(G-SH).min-1.mg-1 
3.30  ±0.43 




0.024 ±0.002 a 0.025 ±0.002 a 0.026 ±0.005 a 0.024 ±0.004 a 
G-SH, mmol.g-1  
0.031 ±0.008 
a* 0.015 ±0.005 b 0.024 ±0.004 a 0.028 ±0.004 a 0.023 ±0.004 ab 
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 Results of CAT and SOD determination are shown in 
Figure 4 and Figure 5, respectively. Treatment had  
a significant influence on both enzymes (p <0.05). 
Alloxan-induced diabetes caused a significant decrease in 
activities of both enzymes, while magnesium 
supplementation restored those values, causing even over-
production of catalase. Both enzymes are important in 
detoxifying ROS produced by alloxan, with SOD reducing 
superoxide radicals to hydrogen peroxide and molecular 
oxygen, and catalase breaking down hydrogen peroxide 
into water and oxygen (Lenzen, 2008). These reactions 
force Fenton reaction, and therefore, production of 
hydroxyl radical, the major damaging ROS related to β cell 
death, to halt (Lenzen, 2008; Munday, 1988; 
Winterbourn and Munday, 1989). It was shown that 
excess of catalase production in liver hepatocytes, also 
possessing GLUT2 transporter and suitable for alloxan 
selective absorption, halted toxic effects of alloxan related 
to ROS production to the minimum (Grankvist et al., 
1979; Tiedge et al., 1997). 
 Data for G-SH and G-Per are shown in Table 3, with 
treatment having a significant influence on their values  
(p <0.05). The results for G-Red were non-significant  
(p >0.05, Table 3). Reduced glutathione is an important 
thiol-containing molecule, the presence of which causes 
alloxan- dialuronic acid cycling, resulting in the eventual 
production of ROS (Lenzen, 2008). Alloxan-induced 
diabetes reduces levels of G-SH, and therefore, decreases 
reduced glutathione/oxidized glutathione ratio  
(G-SH/GSSG). However, increased levels of G-SH in  
β cells have a protective effect for glucokinase (“glucose 
sensor”) inhibition by alloxan, as alloxan is kept in its 
oxidized form, dialuronic acid, incapable of reacting with 
thiol groups of glucokinase and deactivating it (Ighodaro, 
Adeosun and Akinloye, 2017). Secondly, increased levels 
of G-SH cause activation of glutathione peroxidase, one of 
the enzymes capable of hydrogen peroxide deactivation. 
Progressed and established alloxan-induced diabetes 
reduced residual levels of G-SH in pancreatic tissue, 
though magnesium supplementation partially restored )  
G-SH levels to the value found in control animals (Table 
3). A similar effect was observed with G-Per (Table 3), 
which also decomposes hydrogen peroxide. Glutathione 
reductase, which restores reduced glutathione levels 
through the reduction of its oxidized form, GSSG, using 
NADPH as reducing power, remained unchanged between 
treatments (Table 3). 
 Results for LDH and G6PD activity in pancreatic tissue 
after late established alloxan-induced diabetes are shown 
in Figure 6 and Figure 7. Treatment had a significant 
influence on both enzymes (p <0.05), with a significant 
decrease in their activities during late established diabetes 
(group D), and partial restoration in the case of magnesium 
supplementation after the onset of the disease in late 
progression. G6PD is a rate-limiting, first enzyme 
involved in the pentose phosphate pathway, which was 
shown to be inhibited during diabetes in the kidney cortex 
(Xu, Osborne and Stanton, 2005). Pentose phosphate 
pathway generates extra reducing power in the form of 
NADPH, which can serve a substrate for glutathione 
reductase, which transforms oxidized GSSG into reduced 
G-SH, improving antioxidative “health” of the cells (Xu, 
Osborne and Stanton, 2005). The LDH is the final 
enzyme in anaerobic oxidation of glucose, transforming 
pyruvate into lactate, and vice versa. Enzymatic activities 
of both LDH and G6PD in control untreated samples may 
serve as overall cell health state evaluation, and reduction 
in their activities may indicate impaired cellular health. 
 Several mechanisms may cause Mg
2+
 oral 
supplementation positive influence on pancreatic tissue, 
and specifically β cells, during experimentally induced 
diabetes. Magnesium complex with ATP activates 
glucokinase, an enzyme that serves as a “glucose sensor” 
as an initial step in cascade reactions of insulin release 
(Gommers et al., 2016). Though it may happen even at  
a low sub-physiological level, some specific association 
between Mg-ATP and glucokinase may still exist (Molnes 
et al., 2011), possibly decreasing alloxan inhibition of 
glucokinase. Intracellular magnesium concentrations 
inhibit L-type Ca
2+
 opening, avoiding massive Ca
2+
 influx 
inside cells, and “preserving” immediate insulin release 
and initial severe hypoglycemia caused by alloxan. 
Massive Ca
2+
 influx could also be one of the reasons for  
β cells death, besides ROS production (Szkudelski, 2001). 
Magnesium serves as an antagonist of calcium, and more 
importantly, the ratio between Ca and Mg, not 
concentration levels themselves, causes insulin vesicle 
exocytosis (Atwater et al., 1983). Additionally, 
magnesium dietary deficiency decreased antioxidant 
enzyme activities, namely, superoxide dismutase and 
catalase, in rat cardiac tissue, causing oxidative injury and 
explaining the pathogenesis of cardiac lesions in Mg-
deficient rats (Kumar and Shivakumar, 1997). A similar 
protective mechanism may be applied to magnesium 
influence on antioxidant enzymes in the pancreas. 
Contrary, although magnesium-deficient diet in rats caused 
decreased reduced glutathione levels in erythrocytes, 
implying its role in the maintenance of G-SH 
concentration to protect against oxidative damage in the 
erythrocyte membrane, the magnesium-deficient diet 
caused increased reduced glutathione levels in liver and 
kidneys, with no influence on other soft tissues (Hsu, 
Rubenstein and Paleker, 1982). Chaudhary, Boparai 
and Bansal (2007) also showed an individual effect of low 
magnesium diet, as well as a combined effect of low 
magnesium with high sucrose diet on the development of 
oxidative stress in rats, namely, increase in plasma and 
liver lipid hydroperoxide levels, decrease in plasma 
reduced glutathione,  decrease in liver superoxide 
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 Figure 2 Influence of treatment (D, Mg100-D, 
Mg250-D, Mg500-D)  on the mean value of fasting 
blood serum glucose levels on different days (day 21, 
25, 27, 30). Error bars reflect standard error of mean. 
Adapted from Statistica ver 10.0. 
 
 
 Figure 3 Influence of time factor (day 21, 25, 27, 
30) on the mean value of fasting blood serum glucose 
levels in  diabetic (D), magnesium supplemented 
diabetic rats (Mg100-D, Mg250-D, Mg500-D). Error 
bars reflect standard error of mean. Adapted from 
Statistica ver 10.0. 
 
 
Figure 4 Mean values of pancreatic catalase (СAT) 
activity in control (C), diabetic (D), magnesium 
supplemented diabetic rats (Mg100-D, Mg250-D, 
Mg500-D) as measured on day 30 (sacrifice day). 
Error bars reflect standard deviations. Means with the 
same letters are not significantly different (p >0.05). 
 
 
 Figure 5 Mean values of pancreatic superoxide 
dismutase (SOD) activity in control (C), diabetic (D), 
magnesium supplemented diabetic rats (Mg100-D, 
Mg250-D, Mg500-D) as measured on day 30 
(sacrifice day). Error bars reflect standard deviations. 
Means with the same letters are not significantly 




 Figure 6 Mean values of pancreatic lactate 
dehydrogenase (LDH) activity in control (C), 
diabetic (D), magnesium supplemented diabetic rats 
(Mg100-D, Mg250-D,  Mg500-D) as measured on 
day 30 (sacrifice day). Error bars reflect standard 
deviations. Means with the same letters are not 





Figure 7 Mean values of pancreatic glucose-6-
phosphate dehydrogenase (G6PD) activity in control 
(C), diabetic (D), magnesium supplemented diabetic 
rats (Mg-100D,  Mg250-D,  Mg500-D) as measured 
on day 30 (sacrifice day). Error bars reflect standard 
deviations. Means with the same letters are not 
significantly different (p >0.05). 
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CONCLUSION 
 To summarize, daily oral magnesium supplementation at 
a dose of 250 mg.kg
-1
 live weight in advance before 
alloxan-induced diabetes and within 10 days of the 
diabetic state improved fasting glucose levels in rats, 
though did not prevent the onset of diabetes. Oral 
supplementation with magnesium restored glucose 
metabolism enzymes levels, such as LDH and G6PD, in 
diabetic rat pancreas, compared to alloxan-induced 
diabetes alone, which suppressed their activity. 
Additionally, antioxidant system enzymes, namely, 
catalase, superoxide dismutase, glutathione peroxidase, 
and reduced glutathione levels, all improved in pancreatic 
tissue after magnesium administration in late-stage 
diabetic rats. Inconclusive results were obtained regarding 
lipid hydroperoxide, either due to technical issues or lack 
of influence of magnesium on the pancreas due to very late 
testing after the development of diabetes. 
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